Back to search

Article

CAV2 Confers Cetuximab Resistance in HNSCC by Ubiquitin-Mediated Disruption of the PACT-PKR Tumor Suppressor Axis

2026-03-04

Abstract excerpt

<h4>Background: </h4> /Objectives: Head and neck squamous cell carcinoma (HNSCC) frequently exhibits resistance to targeted therapies, including cetuximab. Identifying key drivers of tumor progression and elucidating the mechanisms underlying therapeutic resistance are essential for improving clinical outcomes. This study aimed to investigate the role of Caveolin-2 (CAV2) in HNSCC proliferation and cetuximab resis...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
135d4d58-cd73-59bf-b507-4a0ae44c27e5
DOI
10.20944/preprints202603.0337.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CAV2 Confers Cetuximab Resistance in HNSCC by Ubiquitin-Mediated Disruption of the PACT-PKR Tumor Suppressor AxisDOI 10.20944/preprints202603.0337.v1
Select a neighboring publication to make it the new centre.